These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32615790)

  • 1. New Knowledge About CCR5, HIV Infection, and Disease Progression: Is "Old" Still Valuable?
    Mehlotra RK
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):795-799. PubMed ID: 32615790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 Promoter Polymorphism -2459G > A: Forgotten or Ignored?
    Mehlotra RK
    Cells; 2019 Jun; 8(7):. PubMed ID: 31261839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea.
    Mehlotra RK; Hall NB; Bruse SE; John B; Zikursh MJB; Stein CM; Siba PM; Zimmerman PA
    Infect Genet Evol; 2015 Dec; 36():165-173. PubMed ID: 26397046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
    Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
    BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 haplotypes and mother-to-child HIV transmission in Malawi.
    Pedersen BR; Kamwendo D; Blood M; Mwapasa V; Molyneux M; North K; Rogerson SJ; Zimmerman P; Meshnick SR
    PLoS One; 2007 Sep; 2(9):e838. PubMed ID: 17786209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
    Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
    AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.
    Zapata W; Aguilar-Jiménez W; Pineda-Trujillo N; Rojas W; Estrada H; Rugeles MT
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1594-603. PubMed ID: 24098976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Kostrikis LG; Huang Y; Moore JP; Wolinsky SM; Zhang L; Guo Y; Deutsch L; Phair J; Neumann AU; Ho DD
    Nat Med; 1998 Mar; 4(3):350-3. PubMed ID: 9500612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
    Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
    J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
    Zhang L; He T; Huang Y; Chen Z; Guo Y; Wu S; Kunstman KJ; Brown RC; Phair JP; Neumann AU; Ho DD; Wolinsky SM
    J Virol; 1998 Nov; 72(11):9307-12. PubMed ID: 9765480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of CCR5-Δ32, CCR2-64I and SDF1-3'A alleles in HIV-infected and uninfected patients in Istanbul, Turkey.
    Köksal MO; Akgül B; Beka H; Çiftçi S; Keskin F; Eraksoy H; Ağaçfidan A
    J Infect Dev Ctries; 2021 Aug; 15(8):1183-1189. PubMed ID: 34516427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females.
    Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):293-7. PubMed ID: 18197127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of CCR5 affecting HIV disease progression in the Japanese population.
    Kageyama S; Mimaya J; Yamada K; Kurimura T; Shiraki K;
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):991-5. PubMed ID: 11485615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
    Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
    Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Martin MP; Dean M; Smith MW; Winkler C; Gerrard B; Michael NL; Lee B; Doms RW; Margolick J; Buchbinder S; Goedert JJ; O'Brien TR; Hilgartner MW; Vlahov D; O'Brien SJ; Carrington M
    Science; 1998 Dec; 282(5395):1907-11. PubMed ID: 9836644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.